Comparing low-dose (DART) and enhanced low-dose dexamethasone regimens in preterm infants with bronchopulmonary dysplasia
Frontiers in Pediatrics · 31.10.2023 · 11
DOI: 10.3389/fped.2023.1261316 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pediatrics, online erschienen am 31.10.2023. Verfasst von Heba Mohamed Al-Taweel und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy Department, Women's Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Neonatologie
Abstract (Originalsprache)
Introduction
Determining the optimal dexamethasone dosage for facilitating extubation in extremely low birth weight (ELBW) infants with bronchopulmonary dysplasia (BPD) remains uncertain. This study aims to compare the effectiveness of low-dose (DART) and enhanced low-dose dexamethasone regimens in achieving successful extubation in these infants.
Methods
We conducted a retrospective cohort study at the Women's Wellness and Research Center (WWRC) involving ELBW infants who received dexamethasone for BPD prevention or treatment, or for extubation between January 1st, 2015, and December 31st, 2019. Our goal was to assess successful extubation within various time points of treatement.
Results
A total of 77 patients, matched in gestational age and BW, were enrolled in the study, receiving a total of 121 dexamethasone courses. Low-dose dexamethasone courses were administered 75 times to 49 infants, while 46 courses of enhanced low-dose were given to 28 infants. Treatment commenced at 30.8 ± 3.4 weeks post-menstrual age, compared to 32.1 ± 2.5 weeks in the enhanced low-dose group ( p = 0.014). The median (IQR) course duration was seven (3–10) days in the low-dose group, while it was 10 (8–14) days in the enhanced low-dose group ( p < 0.001). The median (IQR) course dose was 0.73 (0.53–0.86) mg/kg in the low-dose group and 1.27 (0.97–2.05) mg/kg in the enhanced low-dose group ( p < 0.001). There were no differences in extubation success at any time point between the two groups at 72 h and seven days after treatment initiation, by course completion, and within seven days after treatment completion. However, regression analysis identified several predictors of successful extubation; baseline FiO 2 , course duration, and duration of invasive mechanical ventilation were negatively associated with successful extubation at various time points, while received dose per kg and cumulative dose positively correlated with successful extubation at different time points. No significant differences were observed in secondary outcomes, including death or BPD.
Conclusion
The choice between low-dose and enhanced low-dose dexamethasone regimens may not significantly impact extubation success. However, careful consideration of dosing, ventilation status, and treatment duration remains crucial in achieving successful extubation. This study highlights the need for personalized dexamethasone therapy in ELBW infants.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pharmacy Department, Women's Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar.
- Neonatal Intensive Care Unit, Women's Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar.
- Pediatric Department, Children's Hospital of Eastern Ontario and Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada.
- Pediatric Department, Weill Cornell Medicine-Qatar, Doha, Qatar.
Zitieren
APA
Al-Taweel, H. M., Abdelhady, I. S. I., Irfan, N., Khzzam, F. A., Kamal, A., Thazhe, S. B. K., Bayoumi, M. A. A., & Gad, A. (2023). Comparing low-dose (DART) and enhanced low-dose dexamethasone regimens in preterm infants with bronchopulmonary dysplasia. Frontiers in Pediatrics, 11. https://doi.org/10.3389/fped.2023.1261316
Vancouver
Al-Taweel HM, Abdelhady ISI, Irfan N, Khzzam FA, Kamal A, Thazhe SBK, et al. Comparing low-dose (DART) and enhanced low-dose dexamethasone regimens in preterm infants with bronchopulmonary dysplasia. Frontiers in Pediatrics. 2023;11. doi:10.3389/fped.2023.1261316
BibTeX
@article{AlTaweel2023,
author = {Al-Taweel, Heba Mohamed and Abdelhady, Ismail Sabry Ismail and Irfan, Nasreen and Khzzam, Fadi Al and Kamal, Abdullah and Thazhe, Sudheer Babu Kurunthattil and Bayoumi, Mohammad A A and Gad, Ashraf},
title = {Comparing low-dose (DART) and enhanced low-dose dexamethasone regimens in preterm infants with bronchopulmonary dysplasia},
journal = {Frontiers in Pediatrics},
year = {2023},
volume = {11},
doi = {10.3389/fped.2023.1261316}
}
EUVIMED